A risk-based approach to experimental early phase clinical trials during the COVID-19 pandemic.
Lancet Oncol
; 21(7): 889-891, 2020 07.
Article
in En
| MEDLINE
| ID: mdl-32615107
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Clinical Trials, Phase I as Topic
/
Coronavirus Infections
/
Neoplasms
Type of study:
Etiology_studies
/
Risk_factors_studies
Limits:
Humans
Country/Region as subject:
Europa
Language:
En
Journal:
Lancet Oncol
Journal subject:
NEOPLASIAS
Year:
2020
Document type:
Article
Affiliation country:
Country of publication: